Dexamethasone-inhibitable stimulation of plasma prorenin by ketamine in cats

S. Rubattu, D. N. Marion, M. Peterson, J. E. Sealey

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Plasma prorenin in humans is derived from both renal and extrarenal sources, but in the cat most plasma prorenin is normally of renal origin. Sodium depletion and β-adrenergic blockade can increase plasma prorenin in cats, but the effects of sedatives and glucocorticoids are unknown. We examined the effect of ketamine, a centrally acting nonbarbiturate anesthetic, and of the glucocorticoid dexamethasone on plasma prorenin and renin. Intramuscular injection of ketamine (20 mg/kg, three times a day) for 4 days increased plasma prorenin slowly and consistently, from 7.4 ± 1.4 (± SEM) to 11.4 ± 2.2, 17.1 ± 2.5, 20.2 ± 3.0, and 29.2 ± 3.4 ng/ml · h (P <0.001) on days 1, 2, 3, and 4, respectively, without any effect on plasma active renin. Plasma renin substrate and cortisol were also unchanged. Bilateral nephrectomy reduced both baseline and stimulated plasma prorenin to undetectable levels. Treatment with α1-blocker, β1-blocker, angiotensin-converting enzyme inhibitor, or Ca2+ antagonist did not affect the rise in prorenin induced by ketamine, but dexamethasone completely blocked the response. In contrast, dexamethasone alone had little effect on plasma prorenin. These results demonstrate that repetitive ketamine administration selectively increases plasma prorenin, suggesting that renal prorenin secretion may be regulated independently of active renin. Blockade of stimulated, but not baseline, plasma prorenin by dexamethasone is consistent with a negative effect of glucocorticoids on the regulatory elements of the renin gene.

Original languageEnglish
Pages (from-to)1533-1539
Number of pages7
JournalEndocrinology
Volume125
Issue number3
Publication statusPublished - 1989

Fingerprint

Ketamine
Renin
Dexamethasone
Cats
Glucocorticoids
Kidney
Angiotensinogen
Intramuscular Injections
Nephrectomy
Hypnotics and Sedatives
Angiotensin-Converting Enzyme Inhibitors
Adrenergic Agents
Anesthetics
Hydrocortisone

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism

Cite this

Rubattu, S., Marion, D. N., Peterson, M., & Sealey, J. E. (1989). Dexamethasone-inhibitable stimulation of plasma prorenin by ketamine in cats. Endocrinology, 125(3), 1533-1539.

Dexamethasone-inhibitable stimulation of plasma prorenin by ketamine in cats. / Rubattu, S.; Marion, D. N.; Peterson, M.; Sealey, J. E.

In: Endocrinology, Vol. 125, No. 3, 1989, p. 1533-1539.

Research output: Contribution to journalArticle

Rubattu, S, Marion, DN, Peterson, M & Sealey, JE 1989, 'Dexamethasone-inhibitable stimulation of plasma prorenin by ketamine in cats', Endocrinology, vol. 125, no. 3, pp. 1533-1539.
Rubattu, S. ; Marion, D. N. ; Peterson, M. ; Sealey, J. E. / Dexamethasone-inhibitable stimulation of plasma prorenin by ketamine in cats. In: Endocrinology. 1989 ; Vol. 125, No. 3. pp. 1533-1539.
@article{e3fd8d809c7f4db2aaf5868f225ad3ef,
title = "Dexamethasone-inhibitable stimulation of plasma prorenin by ketamine in cats",
abstract = "Plasma prorenin in humans is derived from both renal and extrarenal sources, but in the cat most plasma prorenin is normally of renal origin. Sodium depletion and β-adrenergic blockade can increase plasma prorenin in cats, but the effects of sedatives and glucocorticoids are unknown. We examined the effect of ketamine, a centrally acting nonbarbiturate anesthetic, and of the glucocorticoid dexamethasone on plasma prorenin and renin. Intramuscular injection of ketamine (20 mg/kg, three times a day) for 4 days increased plasma prorenin slowly and consistently, from 7.4 ± 1.4 (± SEM) to 11.4 ± 2.2, 17.1 ± 2.5, 20.2 ± 3.0, and 29.2 ± 3.4 ng/ml · h (P <0.001) on days 1, 2, 3, and 4, respectively, without any effect on plasma active renin. Plasma renin substrate and cortisol were also unchanged. Bilateral nephrectomy reduced both baseline and stimulated plasma prorenin to undetectable levels. Treatment with α1-blocker, β1-blocker, angiotensin-converting enzyme inhibitor, or Ca2+ antagonist did not affect the rise in prorenin induced by ketamine, but dexamethasone completely blocked the response. In contrast, dexamethasone alone had little effect on plasma prorenin. These results demonstrate that repetitive ketamine administration selectively increases plasma prorenin, suggesting that renal prorenin secretion may be regulated independently of active renin. Blockade of stimulated, but not baseline, plasma prorenin by dexamethasone is consistent with a negative effect of glucocorticoids on the regulatory elements of the renin gene.",
author = "S. Rubattu and Marion, {D. N.} and M. Peterson and Sealey, {J. E.}",
year = "1989",
language = "English",
volume = "125",
pages = "1533--1539",
journal = "Endocrinology",
issn = "0013-7227",
publisher = "The Endocrine Society",
number = "3",

}

TY - JOUR

T1 - Dexamethasone-inhibitable stimulation of plasma prorenin by ketamine in cats

AU - Rubattu, S.

AU - Marion, D. N.

AU - Peterson, M.

AU - Sealey, J. E.

PY - 1989

Y1 - 1989

N2 - Plasma prorenin in humans is derived from both renal and extrarenal sources, but in the cat most plasma prorenin is normally of renal origin. Sodium depletion and β-adrenergic blockade can increase plasma prorenin in cats, but the effects of sedatives and glucocorticoids are unknown. We examined the effect of ketamine, a centrally acting nonbarbiturate anesthetic, and of the glucocorticoid dexamethasone on plasma prorenin and renin. Intramuscular injection of ketamine (20 mg/kg, three times a day) for 4 days increased plasma prorenin slowly and consistently, from 7.4 ± 1.4 (± SEM) to 11.4 ± 2.2, 17.1 ± 2.5, 20.2 ± 3.0, and 29.2 ± 3.4 ng/ml · h (P <0.001) on days 1, 2, 3, and 4, respectively, without any effect on plasma active renin. Plasma renin substrate and cortisol were also unchanged. Bilateral nephrectomy reduced both baseline and stimulated plasma prorenin to undetectable levels. Treatment with α1-blocker, β1-blocker, angiotensin-converting enzyme inhibitor, or Ca2+ antagonist did not affect the rise in prorenin induced by ketamine, but dexamethasone completely blocked the response. In contrast, dexamethasone alone had little effect on plasma prorenin. These results demonstrate that repetitive ketamine administration selectively increases plasma prorenin, suggesting that renal prorenin secretion may be regulated independently of active renin. Blockade of stimulated, but not baseline, plasma prorenin by dexamethasone is consistent with a negative effect of glucocorticoids on the regulatory elements of the renin gene.

AB - Plasma prorenin in humans is derived from both renal and extrarenal sources, but in the cat most plasma prorenin is normally of renal origin. Sodium depletion and β-adrenergic blockade can increase plasma prorenin in cats, but the effects of sedatives and glucocorticoids are unknown. We examined the effect of ketamine, a centrally acting nonbarbiturate anesthetic, and of the glucocorticoid dexamethasone on plasma prorenin and renin. Intramuscular injection of ketamine (20 mg/kg, three times a day) for 4 days increased plasma prorenin slowly and consistently, from 7.4 ± 1.4 (± SEM) to 11.4 ± 2.2, 17.1 ± 2.5, 20.2 ± 3.0, and 29.2 ± 3.4 ng/ml · h (P <0.001) on days 1, 2, 3, and 4, respectively, without any effect on plasma active renin. Plasma renin substrate and cortisol were also unchanged. Bilateral nephrectomy reduced both baseline and stimulated plasma prorenin to undetectable levels. Treatment with α1-blocker, β1-blocker, angiotensin-converting enzyme inhibitor, or Ca2+ antagonist did not affect the rise in prorenin induced by ketamine, but dexamethasone completely blocked the response. In contrast, dexamethasone alone had little effect on plasma prorenin. These results demonstrate that repetitive ketamine administration selectively increases plasma prorenin, suggesting that renal prorenin secretion may be regulated independently of active renin. Blockade of stimulated, but not baseline, plasma prorenin by dexamethasone is consistent with a negative effect of glucocorticoids on the regulatory elements of the renin gene.

UR - http://www.scopus.com/inward/record.url?scp=0024423445&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024423445&partnerID=8YFLogxK

M3 - Article

C2 - 2667961

AN - SCOPUS:0024423445

VL - 125

SP - 1533

EP - 1539

JO - Endocrinology

JF - Endocrinology

SN - 0013-7227

IS - 3

ER -